Replies to post #189381 on Biotech Values

[DewDiligence]

OCRX Outcomes Table for DSMB Actions in STOP-HE Study

 
                          Estimated    Expected %Chg 
 Outcome                 Probability   in Share Price 
  
 Continue w/o change         54%        +40% or more 
  
 Upsize enrollment           42%        -15% 
  
 Stop for futility/safety     4%        -75% 

JMHO, FWIW